Clinical Trial Update: Valganciclovir in Congenital CMV Infants [Phase 1, Phase 2]

View source ↗

Summary

This update indicates a completed Phase 1/2 clinical trial evaluating valganciclovir in infants with congenital cytomegalovirus infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Cytomegalovirus Infection

Drugs mentioned

• Valganciclovir (Valganciclovir)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Cytomegalovirus Infections | Phase 1, Phase 2 | Status: COMPLETED